Publication

Synthesis and anti-HIV activity of conformationally restricted bicyclic hexahydroisobenzofuran nucleoside analogs

Downloadable Content

Persistent URL
Last modified
  • 05/21/2025
Type of Material
Authors
    Alba Diaz-Rodriguez, University of California, San DiegoYogesh S. Sanghvi, Rasayan Inc.Susana Fernandez, Universidad de OviedoRaymond Schinazi, Emory UniversityEmmanuel A. Theodorakis, University of California, San DiegoMiguel Ferrero, Universidad de OviedoVicente Gotor, Universidad de Oviedo
Language
  • English
Date
  • 2009-01-01
Publisher
  • ROYAL SOC CHEMISTRY
Publication Version
Copyright Statement
  • 2009
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 7
Issue
  • 7
Start Page
  • 1415
End Page
  • 1423
Grant/Funding Information
  • Financial support of this work by the Spanish Ministerio de Educación y Ciencia (MEC) (Project MEC-07-CTQ-61126) is gratefully acknowledged. A. D.-R. thanks MEC for a predoctoral fellowship. We also thank Dr A. G. DiPasquale and Professor A. L. Rheingold (UCSD X-Ray Facility) for the reported crystallographic studies and Dr Y. Su (UCSD Mass Spectrometry Facility) for mass analysis and the NSF (CHE-0116662, CHE-9709183 and CHE-0741968) for NMR and MS instrumentation grants. R. F. S. is supported in part by NIH grants 5P30-AI-50409 (CFAR), 5R37-AI-041980 and by the Department of Veterans Affairs.
Supplemental Material (URL)
Abstract
  • A chiral synthesis of a series of hexahydroisobenzofuran (HIBF) nucleosides has been accomplished via glycosylation of a stereo-defined (syn-isomer) sugar motif 16 with the appropriate silylated bases. All nucleoside analogs were obtained in 52-71% yield as a mixture of α- and β-anomeric products increasing the breadth of the novel nucleosides available for screening. The structure of the novel bicyclic HIBF nucleosides was established by a single crystal X-ray structure of the β-HIBF thymine analog 22b. Furthermore, the sugar conformation for these nucleosides was established as N-type. Among the novel HIBF nucleosides synthesized, twenty-five compounds were tested as inhibitor of HIV-1 in human peripheral blood mononuclear (PBM) cells and seven were found to be active (EC50 = 12.3-36.2 μM). Six of these compounds were purine analogs with β-HIBF inosine analog 22o being the most potent (EC50 = 12.3 μM) among all compounds tested. The striking resemblance between didanosine (ddI) and 22o may explain the potent anti-HIV activity. © 2009 The Royal Societ of Chemistry.
Author Notes
Keywords
Research Categories
  • Health Sciences, Public Health
  • Chemistry, Organic
  • Biology, Virology

Tools

Relations

In Collection:

Items